Video Experimental Relacionado
Updated: Feb 11, 2026
06:09
Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
7.4K
El progreso de la investigación sobre la enfermedad granulomatosa crónica en niños
Zhixiu Zhang1, Wanyi Li1, Yongjun Wang1
1The Second Department of Pediatric Respiratory, Gansu Provincial Maternity and Child-Care Hospital/Central Hospital in Gansu Province, Gansu Province, CHN.
Cureus
|February 10, 2026
Resumen
La enfermedad granulomatosa crónica (CGD) es una inmunodeficiencia rara en la que los neutrófilos no pueden combatir las infecciones, que afecta principalmente a los niños. Los tratamientos actuales incluyen trasplantes de células madre, con la terapia génica emergiendo como una alternativa prometedora.
Área de la Ciencia:
- Inmunología Inmunología.
- Genética La genética.
- La pediatría es la medicina de los niños.
Sus antecedentes:
- La enfermedad granulomatosa crónica (MGC) es una inmunodeficiencia primaria.
- Se deriva de un estallido oxidativo defectuoso de neutrófilos, que perjudica la defensa del huésped.
- La CGD aumenta la susceptibilidad a infecciones graves y presenta complicaciones no infecciosas.
Objetivo del estudio:
- Revisar la fisiopatología, la genética y los aspectos clínicos de la CGD pediátrica.
- Para discutir los desafíos de diagnóstico y las terapias actuales / emergentes.
- Proporcionar información para mejorar el diagnóstico clínico de CGD en niños.
Principales métodos:
- Revisión de la literatura que se centra en el CGD pediátrico.
- Análisis de la fisiopatología, la genética molecular y la epidemiología.
- Evaluación de métodos de diagnóstico y terapias celulares.
Principales resultados:
- La CGD exhibe herencia recesiva autosómica y ligada al gen X.
- Los pacientes pediátricos con CGD a menudo se enfrentan a infecciones potencialmente mortales.
- El diagnóstico puede ser difícil, ya que requiere pruebas especializadas.
Conclusiones:
- El trasplante de células madre hematopoyéticas (HSCT) es el tratamiento curativo establecido.
- La terapia génica presenta una alternativa prometedora y más segura para la CGD.
- La investigación adicional y el diagnóstico precoz son cruciales para el manejo de la CGD pediátrica.
Videos de Conceptos Relacionados
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:25Chronic Kidney Disease I: Introduction
762
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
762
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:24Chronic Kidney Disease II: Clinical Manifestations
679
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
679